LXRXLEXICON PHARMACEUTICALS, INC.

Nasdaq lexpharma.com


$ 1.58 $ 0.04 (2.6 %)    

Friday, 26-Apr-2024 15:59:40 EDT
QQQ $ 431.01 $ 6.55 (1.54 %)
DIA $ 382.27 $ 1.39 (0.36 %)
SPY $ 508.26 $ 4.77 (0.95 %)
TLT $ 88.26 $ 0.46 (0.52 %)
GLD $ 216.60 $ 0.70 (0.32 %)
$ 1.58
$ 1.55
$ 0.00 x 0
$ 0.00 x 0
$ 1.54 - $ 1.60
$ 0.92 - $ 3.79
1,271,998
na
389.05M
$ 1.06
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 03-25-2024 12-31-2023 10-K
2 11-08-2023 09-30-2023 10-Q
3 08-04-2023 06-30-2023 10-Q
4 05-04-2023 03-31-2023 10-Q
5 03-03-2023 12-31-2022 10-K
6 11-09-2022 09-30-2022 10-Q
7 08-03-2022 06-30-2022 10-Q
8 05-05-2022 03-31-2022 10-Q
9 03-10-2022 12-31-2021 10-K
10 11-09-2021 09-30-2021 10-Q
11 08-06-2021 06-30-2021 10-Q
12 05-06-2021 03-31-2021 10-Q
13 03-12-2021 12-31-2020 10-K
14 10-30-2020 09-30-2020 10-Q
15 07-29-2020 06-30-2020 10-Q
16 04-27-2020 03-31-2020 10-Q
17 03-12-2020 12-31-2019 10-K
18 11-07-2019 09-30-2019 10-Q
19 08-01-2019 06-30-2019 10-Q
20 05-01-2019 03-31-2019 10-Q
21 03-15-2019 12-31-2018 10-K
22 11-01-2018 09-30-2018 10-Q
23 07-30-2018 06-30-2018 10-Q
24 05-03-2018 03-31-2018 10-Q
25 03-01-2018 12-31-2017 10-K
26 11-08-2017 09-30-2017 10-Q
27 08-01-2017 06-30-2017 10-Q
28 05-04-2017 03-31-2017 10-Q
29 03-06-2017 12-31-2016 10-K
30 11-07-2016 09-30-2016 10-Q
31 08-04-2016 06-30-2016 10-Q
32 05-05-2016 03-31-2016 10-Q
33 03-11-2016 12-31-2015 10-K
34 11-09-2015 09-30-2015 10-Q
35 08-07-2015 06-30-2015 10-Q
36 05-05-2015 03-31-2015 10-Q
37 03-12-2015 12-31-2014 10-K
38 11-06-2014 09-30-2014 10-Q
39 08-07-2014 06-30-2014 10-Q
40 05-08-2014 03-31-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 needham-reiterates-hold-on-lexicon-pharmaceuticals

Needham analyst Joseph Stringer reiterates Lexicon Pharmaceuticals (NASDAQ:LXRX) with a Hold.

 needham-reiterates-hold-on-lexicon-pharmaceuticals

Needham analyst Joseph Stringer reiterates Lexicon Pharmaceuticals (NASDAQ:LXRX) with a Hold.

 why-luxurban-hotels-shares-are-trading-lower-by-around-27-here-are-other-stocks-moving-in-wednesdays-mid-day-session

Shares of LuxUrban Hotels Inc. (NASDAQ: LUXH) fell sharply during Wednesday’s session after the company issued preliminary fo...

 cintas-reports-upbeat-earnings-joins-paysign-noah-holdings-and-other-big-stocks-moving-higher-on-wednesday

U.S. stocks were higher, with the Dow Jones index gaining around 300 points on Wednesday.

 lexicon-pharmaceuticals-announces-clinical-data-on-the-impact-of-sotagliflozin-on-stroke-and-heart-attack-risk-among-four-lexicon-sponsored-presentations-at-the-american-college-of-cardiology-73rd-annual-scientific-session--expo

Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) today announced that four data presentations related to sotagliflozin, an inhibitor...

 lexicon-pharmaceuticals-inc-announces-new-post-hoc-analysis-of-intandem3-study-demonstrates-improvements-in-glycemic-control-with-sotagliflozin-treatment-in-patients-with-type-1-diabetes-and-chronic-kidney-disease

Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) today announced that a post hoc analysis of clinical data from its inTandem3 Phase ...

 acadia-pharmaceuticals-ocular-therapeutix-asana-and-other-big-stocks-moving-lower-in-tuesdays-pre-market-session

U.S. stock futures were mixed this morning, with the Nasdaq futures gaining by around 50 points on Tuesday.

 dow-turns-higher-gds-holdings-shares-climb

U.S. stocks traded mixed toward the end of trading, with the Dow Jones index turning higher on Monday. The Dow traded up 0.08%...

 why-mesoblast-shares-are-trading-higher-by-13-here-are-other-stocks-moving-in-mondays-mid-day-session

Shares of Mesoblast Limited (NASDAQ: MESO) rose sharply during Monday’s session after the company announced FDA support of an ...

 crude-oil-edges-higher-lexicon-pharmaceuticals-shares-jump

U.S. stocks traded lower midway through trading, with the Dow Jones index dipping over 50 points on Monday. The Dow traded dow...

 lexicon-pharmaceuticals-q4-eps-020-beats-022-estimate-cash-position-170m

Lexicon Pharmaceuticals (NASDAQ:LXRX) reported quarterly losses of $(0.20) per share which beat the analyst consensus estimate ...

 why-fluor-shares-are-trading-lower-by-around-8-here-are-other-stocks-moving-in-tuesdays-mid-day-session

Shares of Fluor Corporation (NYSE: FLR) fell during Tuesday’s session following fourth-quarter results.

 top-4-health-care-stocks-you-may-want-to-dump-in-february

As of Feb. 15, 2024, four stocks in the health care sector could be flashing a real warning to investors who value momentum as ...

 lexicon-pharmaceuticals-announced-a-business-and-pipeline-update-at-the-42nd-annual-jp-morgan-healthcare-conference

INPEFA Launch Positioned for Acceleration in 2024- Clinical Data and FDA Feedback Support INPEFA Life Cycle Management Oppor...

 insiders-buying-blend-labs-and-3-other-stocks-under-2

The Dow Jones closed higher by over 50 points on Monday. When insiders purchase or sell shares, it indicates their confidence o...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION